Mehal says
If you are taking Ozempic and have questions about its effects on sexual functionwhether positive or negativeyour diabetes care team is the appropriate resource for evidence-based guidance tailored to your individual circumstances
Ranked by 2024 Global Sales: 1 Ozempic (semaglutide) $16.7 Bn | Novo Nordisk 2 Mounjaro (tirzepatide) $11.5 Bn | Eli Lilly 3 Jardiance (empagliflozin) $9.5 Bn | Boehringer Ingelheim & Eli Lilly 4 Forxiga (dapagliflozin) $7.7 Bn | AstraZeneca 5 Trulicity (dulaglutide) $5.3 Bn | Eli Lilly 6 Rybelsus (semaglutide) $3.2 Bn | Novo Nordisk 7 Humalog (insulin lispro) $2.3 Bn | Eli Lilly 8 NovoRapid (insulin aspart) $2.3 Bn | Novo Nordisk 9 Jentadueto / Trajenta (linagliptin) $1.8 Bn | Boehringer Ingelheim Lantus (insulin glargine) $1.7 Bn | Sanofi Key Insight: The dominance of incretin-based therapies underscores a clear industry shift toward multi-benefit, patient-centric treatments
.,Wang-C-C,Shi-H-H,XuJ,YanagitaT,XueC-H,Zhang-T-TWangY-MDocosahexaenoic acid-acylated astaxanthin ester exhibits superior performance over non-esterified astaxanthin in preventing behavioral deficits coupled with apoptosis in MPTP-induced mice with Parkinsons disease.2020;11(9):80388050
Another study (78) showed that Ex-4 improved neurological deficits after stroke in mice, and the neuroprotective effects of Ex-4 were achieved when administrated intravenously acutely at the onset of stroke or 1 h later, but were lost at 3 h
PMCID: PMC4832555
